Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
Haemonetics (NYSE: HAE) has announced its plans to release second quarter fiscal year 2025 financial results on Thursday, November 7, 2024, at 6:00 am ET. The company will host a conference call with investors and analysts at 8:00 am ET on the same day to discuss the results and answer questions. Interested parties can access the call via teleconference or through a live webcast on Haemonetics' investor relations website. Registration is required for the teleconference, and participants are advised to join 10 minutes before the event start. A replay of the conference call and webcast will be available for one year starting from November 7, 2024, at 11:00 am ET.
Haemonetics (NYSE: HAE) ha annunciato i suoi piani per rilasciare i risultati finanziari del secondo trimestre dell'anno fiscale 2025 il gioved矛 7 novembre 2024, alle 6:00 EST. L'azienda ospiter脿 una conferenza telefonica con investitori e analisti alle 8:00 EST lo stesso giorno per discutere i risultati e rispondere alle domande. Le parti interessate possono accedere alla chiamata tramite teleconferenza o attraverso una trasmissione in diretta sul sito web delle relazioni con gli investitori di Haemonetics. La registrazione 猫 necessaria per la teleconferenza, e si consiglia ai partecipanti di unirsi 10 minuti prima dell'inizio dell'evento. Una registrazione della conferenza e della trasmissione sar脿 disponibile per un anno a partire dal 7 novembre 2024, alle 11:00 EST.
Haemonetics (NYSE: HAE) ha anunciado sus planes para publicar los resultados financieros del segundo trimestre del a帽o fiscal 2025 el jueves 7 de noviembre de 2024, a las 6:00 a.m. ET. La compa帽铆a llevar谩 a cabo una conferencia telef贸nica con inversores y analistas a las 8:00 a.m. ET el mismo d铆a para discutir los resultados y responder preguntas. Las partes interesadas pueden acceder a la llamada a trav茅s de teleconferencia o mediante una transmisi贸n en vivo en el sitio web de relaciones con los inversores de Haemonetics. Es necesaria la registraci贸n para la teleconferencia, y se aconseja a los participantes unirse 10 minutos antes del inicio del evento. Una repetici贸n de la conferencia telef贸nica y la transmisi贸n estar谩 disponible durante un a帽o a partir del 7 de noviembre de 2024, a las 11:00 a.m. ET.
Haemonetics (NYSE: HAE)電� 2025 須岅硠鞐半弰 2攵勱赴 鞛 瓴瓣臣毳� 2024雲� 11鞗� 7鞚� 氇╈殧鞚� 鞓れ爠 6鞁� (ET)鞐� 氚滍憸頃� 瓿勴殟鞚措澕瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 臧欖潃 雮� 鞓れ爠 8鞁� (ET)鞐� 韴瀽鞛� 氚� 攵勳劃臧�鞕�鞚� 鞝勴檾 須岇潣毳� 臧滌禍頃橃棳 瓴瓣臣毳� 雲检潣頃橁碃 歆堧鞐� 雼惦硛頃� 鞓堨爼鞛呺媹雼�. 甏�鞁� 鞛堧姅 攵勲摛鞚� Haemonetics鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐愳劀 鞝勴檾 須岇潣 霕愲姅 靸濎瓿勳棎 鞝戩啀頃� 靾� 鞛堨姷雼堧嫟. 鞝勴檾 須岇潣鞐� 彀胳劃頃橂牑氅� 霌彪鞚� 頃勳殧頃橂┌, 彀胳劃鞛愲姅 鞚措菠韸� 鞁滌瀾 10攵� 鞝勳棎 彀胳棳頃� 瓴冹潉 甓岇灔頃╇媹雼�. 鞝勴檾 須岇潣 氚� 鞗轨簮鞀ろ姼鞚� 雼れ嫓氤搓赴電� 2024雲� 11鞗� 7鞚� 鞓れ爠 11鞁� (ET)攵�韯� 1雲� 霃欖晥 鞝滉车霅╇媹雼�.
Haemonetics (NYSE: HAE) a annonc茅 ses projets de publier les r茅sultats financiers du deuxi猫me trimestre de l'exercice 2025 le jeudi 7 novembre 2024 脿 6h00 ET. L'entreprise organisera une conf茅rence t茅l茅phonique avec des investisseurs et des analystes le m锚me jour 脿 8h00 ET pour discuter des r茅sultats et r茅pondre aux questions. Les parties int茅ress茅es peuvent acc茅der 脿 l'appel par t茅l茅conf茅rence ou via un webinaire en direct sur le site web des relations investisseurs de Haemonetics. L'inscription est requise pour la t茅l茅conf茅rence, et il est conseill茅 aux participants de se connecter 10 minutes avant le d茅but de l'茅v茅nement. Un replay de la conf茅rence t茅l茅phonique et du webinaire sera disponible pendant un an 脿 partir du 7 novembre 2024 脿 11h00 ET.
Haemonetics (NYSE: HAE) hat seine Pl盲ne bekannt gegeben, die finanziellen Ergebnisse f眉r das zweite Quartal des Gesch盲ftsjahres 2025 am Donnerstag, den 7. November 2024, um 6:00 Uhr ET zu ver枚ffentlichen. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz mit Investoren und Analysten abhalten, um die Ergebnisse zu er枚rtern und Fragen zu beantworten. Interessierte Parteien k枚nnen 眉ber eine Telefonkonferenz oder eine Live-Webcast auf der Investor-Relations-Website von Haemonetics an der Sitzung teilnehmen. Eine Registrierung f眉r die Telefonkonferenz ist erforderlich, und die Teilnehmer werden gebeten, 10 Minuten vor Beginn der Veranstaltung beizutreten. Eine Wiederholung der Telefonkonferenz und des Webcasts wird f眉r ein Jahr ab 7. November 2024, um 11:00 Uhr ET verf眉gbar sein.
- None.
- None.
The call can be accessed via teleconference at: 听Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: 听
A replay of the conference call and webcast will be available for one year beginning on November 7, 2024 at 11:00 am ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics听(NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit听.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David听Trenk, Manager-Investor Relations |
(781) 356-9763 听 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications 听 | |
(781) 356-9776 | |
View original content to download multimedia:
SOURCE Haemonetics Corporation
FAQ
When will Haemonetics (HAE) release its Q2 FY2025 financial results?
What time is Haemonetics' (HAE) Q2 FY2025 earnings conference call scheduled for?
How can investors access Haemonetics' (HAE) Q2 FY2025 earnings call?
Will a replay of Haemonetics' (HAE) Q2 FY2025 earnings call be available?
